Nir Giladi
#107,320
Most Influential Person Now
Nir Giladi's AcademicInfluence.com Rankings
Nir Giladimedical Degrees
Medical
#1373
World Rank
#1704
Historical Rank
Neurology
#121
World Rank
#183
Historical Rank
Nir Giladiphilosophy Degrees
Philosophy
#4399
World Rank
#6894
Historical Rank
Logic
#1859
World Rank
#2715
Historical Rank
Download Badge
Medical Philosophy
Nir Giladi's Degrees
- Doctorate Medicine Tel Aviv University
- PhD Neurology Tel Aviv University
Why Is Nir Giladi Influential?
(Suggest an Edit or Addition)Nir Giladi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease (2004) (1771)
- The role of executive function and attention in gait (2008) (1710)
- Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena (2004) (1145)
- Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. (2009) (965)
- Freezing of gait: moving forward on a mysterious clinical phenomenon (2011) (930)
- Dual tasking, gait rhythmicity, and Parkinson's disease: Which aspects of gait are attention demanding? (2005) (722)
- Dual‐tasking effects on gait variability: The role of aging, falls, and executive function (2006) (650)
- Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease (2003) (607)
- Wearable Assistant for Parkinson’s Disease Patients With the Freezing of Gait Symptom (2010) (507)
- Walking is more like catching than tapping: gait in the elderly as a complex cognitive task (2005) (481)
- Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson's disease and their carers. (2009) (453)
- Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa (2003) (449)
- Executive control deficits as a prodrome to falls in healthy older adults: a prospective study linking thinking, walking, and falling. (2010) (435)
- Impaired regulation of stride variability in Parkinson's disease subjects with freezing of gait (2003) (426)
- Motor blocks in Parkinson's disease (1992) (417)
- Neurological gait disorders in elderly people: clinical approach and classification (2007) (402)
- Rhythmic auditory stimulation modulates gait variability in Parkinson's disease (2007) (390)
- The natural history of multiple system atrophy: a prospective European cohort study (2013) (376)
- Executive Function and Falls in Older Adults: New Findings from a Five-Year Prospective Study Link Fall Risk to Cognition (2012) (375)
- Properties of the ‘Timed Up and Go’ Test: More than Meets the Eye (2010) (374)
- Dual-task decrements in gait: contributing factors among healthy older adults. (2008) (373)
- The power of cueing to circumvent dopamine deficits: A review of physical therapy treatment of gait disturbances in Parkinson's disease (2002) (368)
- Virtual reality for gait training: can it induce motor learning to enhance complex walking and reduce fall risk in patients with Parkinson's disease? (2011) (352)
- Freezing of gait in patients with advanced Parkinson's disease (2001) (348)
- Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage (2008) (344)
- Treadmill walking as an external pacemaker to improve gait rhythm and stability in Parkinson's disease (2005) (342)
- Gait asymmetry in patients with Parkinson’s disease and elderly fallers: when does the bilateral coordination of gait require attention? (2007) (335)
- Globus pallidus internus pallidotomy for generalized dystonia (1997) (334)
- Validation of the freezing of gait questionnaire in patients with Parkinson's disease (2009) (332)
- Freezing of gait in PD (2001) (328)
- Is freezing of gait in Parkinson's disease related to asymmetric motor function? (2005) (321)
- Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson's disease: a pilot study. (2007) (314)
- Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset (2008) (292)
- A new measure for quantifying the bilateral coordination of human gait: effects of aging and Parkinson’s disease (2007) (287)
- Effects of Cognitive Challenge on Gait Variability in Patients with Parkinson’s Disease (2003) (281)
- Freezing of gait affects quality of life of peoples with Parkinson's disease beyond its relationships with mobility and gait (2007) (280)
- Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease (2006) (273)
- How Does Explicit Prioritization Alter Walking During Dual-Task Performance? Effects of Age and Sex on Gait Speed and Variability (2010) (268)
- Freezing of gait: a practical approach to management (2015) (262)
- Effect of gait speed on gait rhythmicity in Parkinson's disease: variability of stride time and swing time respond differently (2005) (252)
- The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk? (2011) (251)
- Gait impairments in Parkinson's disease (2019) (251)
- Primary Dystonia Is More Responsive than Secondary Dystonia to Pallidal Interventions: Outcome after Pallidotomy or Pallidal Deep Brain Stimulation (2004) (247)
- Differential effects of severe vs mild GBA mutations on Parkinson disease (2015) (246)
- Does the Evaluation of Gait Quality During Daily Life Provide Insight Into Fall Risk? A Novel Approach Using 3-Day Accelerometer Recordings (2013) (242)
- The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort (2018) (234)
- The role of mental function in the pathogenesis of freezing of gait in Parkinson's disease (2006) (231)
- Do we always prioritize balance when walking? Towards an integrated model of task prioritization (2012) (229)
- Gastric emptying time and gastric motility in patients with Parkinson's disease (2001) (228)
- Subjective memory complaints in elders: depression, anxiety, or cognitive decline? (2013) (227)
- Freezing phenomenon in patients with parkinsonian syndromes (1997) (224)
- Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry (2010) (212)
- Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease (2000) (210)
- Gait instability and fractal dynamics of older adults with a "cautious" gait: why do certain older adults walk fearfully? (2005) (201)
- Rotigotine transdermal patch in early Parkinson's disease: A randomized, double‐blind, controlled study versus placebo and ropinirole (2007) (200)
- Characterizing freezing of gait in Parkinson's disease: Models of an episodic phenomenon (2013) (199)
- Can an accelerometer enhance the utility of the Timed Up & Go Test when evaluating patients with Parkinson's disease? (2010) (199)
- Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus. (2002) (198)
- Red flags for multiple system atrophy (2008) (198)
- The Role of the Frontal Lobe in Complex Walking Among Patients With Parkinson’s Disease and Healthy Older Adults (2016) (195)
- Bilateral coordination of walking and freezing of gait in Parkinson’s disease (2008) (191)
- Increased frontal brain activation during walking while dual tasking: an fNIRS study in healthy young adults (2014) (189)
- Globus pallidus internus deep brain stimulation for dystonic conditions: A prospective audit (2003) (185)
- Toward Automated, At-Home Assessment of Mobility Among Patients With Parkinson Disease, Using a Body-Worn Accelerometer (2011) (183)
- Objective Assessment of Fall Risk in Parkinson's Disease Using a Body-Fixed Sensor Worn for 3 Days (2014) (183)
- A Common Cognitive Profile in Elderly Fallers and in Patients with Parkinson's Disease: The Prominence of Impaired Executive Function and Attention (2006) (181)
- Treadmill training for the treatment of gait disturbances in people with Parkinson’s disease: a mini-review (2009) (171)
- Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson's disease (2007) (170)
- An instrumented timed up and go: the added value of an accelerometer for identifying fall risk in idiopathic fallers (2011) (169)
- Relationship between freezing of gait (FOG) and other features of Parkinson’s: FOG is not correlated with bradykinesia (2003) (169)
- Computer-Based, Personalized Cognitive Training versus Classical Computer Games: A Randomized Double-Blind Prospective Trial of Cognitive Stimulation (2011) (169)
- Rasagiline Mesylate, a New Mao-B Inhibitor for the Treatment of Parkinson's Disease: A Double-Blind Study as Adjunctive Therapy to Levodopa (2000) (168)
- Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors. (2005) (167)
- New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset (2007) (159)
- The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease (2007) (154)
- Gait alterations in healthy carriers of the LRRK2 G2019S mutation (2011) (148)
- A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci (2012) (148)
- The Dynamic Gait Index in healthy older adults: the role of stair climbing, fear of falling and gender. (2009) (146)
- Postural instability and fall risk in Parkinson’s disease: impaired dual tasking, pacing, and bilateral coordination of gait during the “ON” medication state (2011) (144)
- A training program to improve gait while dual tasking in patients with Parkinson's disease: a pilot study. (2012) (143)
- Medical treatment of freezing of gait (2008) (141)
- Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease. (2008) (140)
- Rater-blinded, Prospective Comparison: Quetiapine Versus Clozapine for Parkinson's Disease Psychosis (2006) (140)
- Sexual Dysfunction in Parkinson's Disease (2004) (139)
- Assessing fear of falling: Can a short version of the Activities‐specific Balance Confidence scale be useful? (2006) (134)
- The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease (2013) (131)
- Bilateral coordination of gait and Parkinson’s disease: the effects of dual tasking (2009) (130)
- Falls in outpatients with Parkinson's disease (2005) (129)
- When does walking alter thinking? Age and task associated findings (2009) (129)
- Gray matter atrophy distinguishes between Parkinson disease motor subtypes (2013) (125)
- Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium (2015) (125)
- Effects of Methylphenidate on Cognitive Function and Gait in Patients With Parkinson's Disease: A Pilot Study (2006) (124)
- Efficacy of pharmacological treatment of dystonia: evidence‐based review including meta‐analysis of the effect of botulinum toxin and other cure options (2004) (123)
- Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations (2013) (121)
- The mechanism of action of Botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site (1997) (120)
- A Wearable System to Assist Walking of Parkinson´s Disease Patients (2009) (119)
- Effects of cognitive function on gait and dual tasking abilities in patients with Parkinson’s disease suffering from motor response fluctuations (2010) (119)
- Arm swing as a potential new prodromal marker of Parkinson's disease (2016) (118)
- Association Between Performance on Timed Up and Go Subtasks and Mild Cognitive Impairment: Further Insights into the Links Between Cognitive and Motor Function (2014) (116)
- Consensus-based clinical practice recommendations for the examination and management of falls in patients with Parkinson's disease. (2014) (116)
- Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestry (2017) (110)
- Is every-day walking in older adults more analogous to dual-task walking or to usual walking? Elucidating the gaps between gait performance in the lab and during 24/7 monitoring (2019) (109)
- Model-based and Model-free Machine Learning Techniques for Diagnostic Prediction and Classification of Clinical Outcomes in Parkinson’s Disease (2018) (108)
- GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder (2015) (108)
- Clinical characteristics of elderly patients with a cautious gait of unknown origin (2005) (108)
- Gait festination in Parkinson's disease. (2001) (107)
- Striatal dopa and glucose metabolism in PD patients with freezing of gait (2006) (107)
- Is Freezing of Gait in Parkinson's Disease a Result of Multiple Gait Impairments? Implications for Treatment (2012) (102)
- Health‐related quality of life in multiple system atrophy (2006) (101)
- Freezing of gait. Clinical overview. (2001) (100)
- Changes in oxygenated hemoglobin link freezing of gait to frontal activation in patients with Parkinson disease: an fNIRS study of transient motor-cognitive failures (2015) (99)
- Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson’s disease (2004) (99)
- Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's disease (2018) (98)
- Smoking and tea consumption delay onset of Parkinson's disease. (2009) (95)
- Video-assisted swallowing therapy for patients with Parkinson's disease. (2013) (94)
- Executive cognitive deficits in primary dystonia (2003) (92)
- Tetrabenazine Treatment in Movement Disorders (2004) (91)
- Fluctuation and synchronization of gait intervals and gait force profiles distinguish stages of Parkinson's disease. (2007) (87)
- Objective detection of subtle freezing of gait episodes in Parkinson's disease (2010) (86)
- Time series analysis of leg movements during freezing of gait in Parkinson's disease: akinesia, rhyme or reason? (2003) (86)
- The clinical significance of freezing while turning in Parkinson’s disease (2017) (86)
- Olanzapine in Huntington's disease (2002) (86)
- Effects of walking speed on asymmetry and bilateral coordination of gait. (2013) (85)
- Inhibition, executive function, and freezing of gait. (2014) (84)
- Rivastigmine (Exelon) for dementia in patients with Parkinson's disease (2003) (84)
- Gait and balance in Parkinson’s disease subtypes: objective measures and classification considerations (2014) (82)
- Progression in the LRRK2-Asssociated Parkinson Disease Population (2018) (80)
- New evidence for gait abnormalities among Parkinson’s disease patients who suffer from freezing of gait: insights using a body-fixed sensor worn for 3 days (2015) (79)
- Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics (2004) (79)
- The European Multiple System Atrophy-Study Group (EMSA-SG) (2005) (78)
- Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene. (2018) (77)
- Effects of explicit prioritization on dual task walking in patients with Parkinson's disease. (2012) (77)
- Can Methylphenidate Reduce Fall Risk in Community‐Living Older Adults? A Double‐Blind, Single‐Dose Cross‐Over Study (2008) (76)
- Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial (2015) (76)
- Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis. (2015) (75)
- Self-report of missteps in older adults: a valid proxy of fall risk? (2009) (74)
- Classification of gait disturbances: Distinguishing between continuous and episodic changes (2013) (74)
- Clinical characteristics of neuroleptic-induced parkinsonism (2001) (73)
- A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type (2013) (71)
- Potentials of Enhanced Context Awareness in Wearable Assistants for Parkinson's Disease Patients with the Freezing of Gait Syndrome (2009) (71)
- Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study (2020) (71)
- Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. (2000) (71)
- Quality of sexual life in Parkinson's disease. (2002) (70)
- Hand rhythmic tapping and timing in Parkinson's disease. (2004) (70)
- The contribution of postural control and bilateral coordination to the impact of dual tasking on gait (2013) (68)
- Freezing of gait in older adults with high level gait disorders: association with impaired executive function (2007) (68)
- A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype. (2017) (68)
- Automated detection of near falls: algorithm development and preliminary results (2010) (68)
- LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease (2010) (67)
- Synchrony of rest tremor in multiple limbs in Parkinson's disease: evidence for multiple oscillators (2001) (67)
- Lower cognitive performance in healthy G2019S LRRK2 mutation carriers (2012) (66)
- Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin (2017) (65)
- Disorders of the Oral Cavity in Parkinson's Disease and Parkinsonian Syndromes (2015) (64)
- Gray matter atrophy and freezing of gait in Parkinson's disease: Is the evidence black‐on‐white? (2014) (63)
- Effects of Pharmacological Therapy on Gait and Cognitive Function in Depressed Patients (2007) (63)
- Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers (2015) (63)
- White Matter Hyperintensities in Parkinson’s Disease: Do They Explain the Disparity between the Postural Instability Gait Difficulty and Tremor Dominant Subtypes? (2013) (62)
- Higher serum cholesterol and decreased Parkinson's disease risk: A statin‐free cohort study (2018) (62)
- Effects of Aging on Arm Swing during Gait: The Role of Gait Speed and Dual Tasking (2015) (60)
- The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study (2001) (60)
- Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation (2013) (60)
- [Mitochondrial myopathy]. (1990) (59)
- Gait in attention deficit hyperactivity disorder : effects of methylphenidate and dual tasking. (2007) (57)
- The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations (2001) (57)
- Cognition in multiple system atrophy: neuropsychological profile and interaction with mood (2010) (56)
- Altered brain activation in complex walking conditions in patients with Parkinson's disease. (2016) (55)
- Associations between daily-living physical activity and laboratory-based assessments of motor severity in patients with falls and Parkinson's disease. (2019) (55)
- Disparate effects of training on brain activation in Parkinson disease (2017) (54)
- When is Higher Level Cognitive Control Needed for Locomotor Tasks Among Patients with Parkinson’s Disease? (2017) (54)
- Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk. (2012) (53)
- Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene (2015) (53)
- Ropinirole in Gilles de la Tourette syndrome (2004) (53)
- Gait in attention deficit hyperactivity disorder (2007) (53)
- Anxiety, depression and swallowing disorders in patients with Parkinson's disease. (2009) (52)
- Obstacle avoidance to elicit freezing of gait during treadmill walking (2010) (52)
- Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients (2003) (52)
- Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience (2017) (51)
- The LRRK2 G2019S mutation as the cause of Parkinson’s disease in Ashkenazi Jews (2009) (51)
- High rates and the risk factors for emergency room visits and hospitalization in Parkinson's disease. (2013) (51)
- Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes. (2014) (50)
- High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews. (2016) (50)
- Identifying axial and cognitive correlates in patients with Parkinson’s disease motor subtype using the instrumented Timed Up and Go (2014) (50)
- Central nervous system manifestation of IgG4-related disease. (2014) (49)
- Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans. (2010) (48)
- The role of the prefrontal cortex in freezing of gait in Parkinson’s disease: insights from a deep repetitive transcranial magnetic stimulation exploratory study (2017) (48)
- Automated detection of missteps during community ambulation in patients with Parkinson’s disease: a new approach for quantifying fall risk in the community setting (2014) (48)
- Online detection of freezing of gait in Parkinson's disease patients: a performance characterization (2009) (48)
- The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: A double blind placebo‐controlled pilot study (2007) (47)
- Different phenotypic expression in monozygotic twins with Huntington disease (2004) (47)
- Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations. (2009) (47)
- The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease. (2007) (47)
- Interdisciplinary Teamwork for the Treatment of People with Parkinson’s Disease and Their Families (2014) (46)
- Heart rate changes during freezing of gait in patients with Parkinson's disease (2010) (45)
- Clinical Experience Using a 5-Week Treadmill Training Program With Virtual Reality to Enhance Gait in an Ambulatory Physical Therapy Service (2014) (45)
- Visuornotor control abnormalities in patients with unilateral parkinsonism (1998) (45)
- Perampanel in Parkinson Disease Fluctuations: A Double-Blind Randomized Trial With Placebo and Entacapone (2012) (45)
- Neuropsychological profile of DYT1 dystonia (2006) (45)
- Basal ganglia and beyond: The interplay between motor and cognitive aspects in Parkinson’s disease rehabilitation (2018) (45)
- Trial of Cinpanemab in Early Parkinson's Disease. (2022) (45)
- Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson’s disease (2010) (43)
- Gait disturbances in advanced stages of Parkinson's disease. (2001) (43)
- Application of the Movement Disorder Society prodromal criteria in healthy G2019S‐LRRK2 carriers (2018) (43)
- SPARC: a new approach to quantifying gait smoothness in patients with Parkinson’s disease (2018) (43)
- Hemiparkinsonism‐hemiatrophy syndrome (1990) (42)
- Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers (2013) (42)
- Neuropsychiatric characteristics of GBA-associated Parkinson disease (2016) (42)
- What Can We Learn From Freezing of Gait in Parkinson’s Disease? (2010) (42)
- FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease (2018) (41)
- Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease. (2014) (40)
- Quantitative anal sphincter EMG in multisystem atrophy and 100 controls (2001) (40)
- Piloting the NPF data-driven quality improvement initiative. (2010) (39)
- Balance and gait in older adults with systemic hypertension. (2003) (39)
- Evidence for Differential Effects of 2 Forms of Exercise on Prefrontal Plasticity During Walking in Parkinson’s Disease (2018) (39)
- Altered organization of the dorsal attention network is associated with freezing of gait in Parkinson's disease. (2019) (39)
- Emotional Processing of Personally Familiar Faces in the Vegetative State (2013) (39)
- Use of a refined drug tracer algorithm to estimate prevalence and incidence of Parkinson's disease in a large israeli population. (2011) (39)
- Subjective memory decline in healthy community‐dwelling elders. What does this complain mean? (2010) (39)
- Can a Body-Fixed Sensor Reduce Heisenberg's Uncertainty When It Comes to the Evaluation of Mobility? Effects of Aging and Fall Risk on Transitions in Daily Living. (2016) (38)
- Subcortical Volumes Differ in Parkinson’s Disease Motor Subtypes: New Insights into the Pathophysiology of Disparate Symptoms (2016) (38)
- Consensus for the measurement of the camptocormia angle in the standing patient. (2018) (38)
- Do cognition and other non-motor symptoms decline similarly among patients with Parkinson’s disease motor subtypes? Findings from a 5-year prospective study (2017) (37)
- The effects of reducing fear of falling on locomotion in older adults with a higher level gait disorder (2007) (37)
- A motor learning-based intervention to ameliorate freezing of gait in subjects with Parkinson’s disease (2014) (37)
- REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers (2015) (36)
- Neuroimaging as a Window into Gait Disturbances and Freezing of Gait in Patients with Parkinson’s Disease (2013) (36)
- Quality of life and gender identity in Parkinson’s disease (2005) (35)
- Cognitive function and other non-motor features in non-demented Parkinson’s disease motor subtypes (2015) (34)
- Anal sphincter EMG does not distinguish between multiple system atrophy and Parkinson's disease. (2000) (34)
- Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: a prospective study (2008) (34)
- The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson’s disease (2013) (34)
- Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker? (2014) (34)
- Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism. (2012) (34)
- The Montreal Cognitive Assessment in cognitively-intact elderly: a case for age-adjusted cutoffs. (2014) (34)
- Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia (2006) (34)
- Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease (2002) (33)
- When practice does not make perfect: well-practiced handwriting interferes with the consolidation phase gains in learning a movement sequence (2007) (33)
- Progression of dysautonomia in multiple system atrophy: a prospective study of self‐perceived impairment (2007) (33)
- Methylphenidate for the Treatment of Parkinson Disease and Other Neurological Disorders (2009) (33)
- Treadmill walking reduces pre-frontal activation in patients with Parkinson's disease. (2018) (33)
- Anal sphincter EMG does not distinguish between multiple system atrophy and Parkinson's disease (2000) (33)
- Metabolic topography of the hemiparkinsonism‐hemiatrophy syndrome (1994) (32)
- Using wearables to assess bradykinesia and rigidity in patients with Parkinson’s disease: a focused, narrative review of the literature (2019) (32)
- Introducing a new definition of a near fall: intra-rater and inter-rater reliability. (2014) (32)
- Parkin mutation associated parkinsonism and cognitive decline, comparison to early onset Parkinson’s disease (2004) (31)
- Gently Does It: Humans Outperform a Software Classifier in Recognizing Subtle, Nonstereotypical Facial Expressions (2017) (31)
- Freezing of gait in multiple system atrophy (MSA). (2003) (31)
- Objective characterization of daily living transitions in patients with Parkinson’s disease using a single body-fixed sensor (2016) (31)
- The emerging role of SMPD1 mutations in Parkinson's disease: Implications for future studies. (2015) (30)
- Treatment of patients with early and advanced Parkinson's disease with rotigotine transdermal system: age-relationship to safety and tolerability. (2013) (30)
- Parameters for Predicting Favorable Responses to Botulinum Toxin in Children With Cerebral Palsy (2002) (30)
- Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning (2021) (30)
- Shedding light on walking in the dark: the effects of reduced lighting on the gait of older adults with a higher-level gait disorder and controls (2005) (30)
- Frequent misdiagnosis of adult polyglucosan body disease (2015) (30)
- The Age at Motor Symptoms Onset in LRRK2-Associated Parkinson's Disease is Affected by a Variation in the MAPT Locus: A Possible Interaction (2012) (30)
- Interference to consolidation phase gains in learning a novel movement sequence by handwriting: dependence on laterality and the level of experience with the written sequence (2007) (29)
- High prevalence of malignant melanoma in Israeli patients with Parkinson’s disease (2011) (29)
- Dissociation between spontaneous and reactive flexibility in early Parkinson's disease. (2002) (28)
- Advances in the genetics of Parkinson's disease (2008) (28)
- Hormones and Parkinson's disease (1995) (28)
- Cerebral vasomotor reactivity in Parkinson's disease, multiple system atrophy and pure autonomic failure (2006) (28)
- Botulinum toxin injections to one leg alleviate freezing of gait in a patient with parkinson's disease (1997) (28)
- Natural History of Oppenheim's Dystonia (DYT1) in Israel (2003) (27)
- Falls in Parkinson disease: analysis of a large cross-sectional cohort. (2013) (27)
- R‐R interval variation in Parkinson's disease and multiple system atrophy (2004) (26)
- Pharmacokinetics and efficacy of a novel formulation of carbidopa-levodopa (Accordion Pill®) in Parkinson's disease. (2019) (26)
- High‐Level Gait Disorder: Associations with Specific White Matter Changes Observed on Advanced Diffusion Imaging (2013) (26)
- Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson’s Disease (2020) (26)
- Changes in event-related potentials during dual task walking in aging and Parkinson's disease (2019) (25)
- The Profile of Long-term Parkinson's Disease Survivors with 20 Years of Disease Duration and Beyond. (2015) (25)
- Young Women with PD (2001) (25)
- Ashkenazi Parkinson’s disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries (2009) (25)
- Gait festination in parkinsonism: introduction of two phenotypes (2018) (24)
- A randomized trial of a low‐dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease (2017) (24)
- The clinical approach to gait disturbances in Parkinson's disease; maintaining independent mobility. (2006) (24)
- Gait Measures as Predictors of Poststroke Cognitive Function: Evidence From the TABASCO Study (2015) (24)
- Fall risk is associated with amplified functional connectivity of the central executive network in patients with Parkinson’s disease (2015) (24)
- Transition Between the Timed up and Go Turn to Sit Subtasks: Is Timing Everything? (2016) (24)
- Body-Fixed Sensors for Parkinson Disease. (2015) (24)
- A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's Disease (2020) (24)
- Cross-Sectional Study of the Prevalence of Parkinson’s Disease in the Kibbutz Movement in Israel (2001) (23)
- Prefrontal cortex activation during obstacle negotiation: What’s the effect size and timing? (2018) (23)
- Depressive symptoms may increase the risk of the future development of freezing of gait in patients with Parkinson's disease: Findings from a 5-year prospective study. (2019) (23)
- DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers (2017) (23)
- The use of botulinum toxin to treat "striatal" toes. (1994) (23)
- Gait Disturbances in Parkinson’s Disease (2002) (23)
- Tossing and Turning in Bed: Nocturnal Movements in Parkinson's Disease (2020) (22)
- Age-associated changes in obstacle negotiation strategies: Does size and timing matter? (2018) (22)
- Genetic markers of Restless Legs Syndrome in Parkinson disease. (2015) (22)
- Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort study. (2016) (21)
- Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease (2020) (21)
- Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease (2011) (21)
- A voxel‐based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease‐related G2019S LRRK2 mutation carriers (2014) (21)
- Using Wearable Sensors and Machine Learning to Automatically Detect Freezing of Gait during a FOG-Provoking Test (2020) (21)
- Association between Community Ambulation Walking Patterns and Cognitive Function in Patients with Parkinson's Disease: Further Insights into Motor-Cognitive Links (2015) (21)
- Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease: A Real-life Study (2016) (20)
- The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of events. (2019) (20)
- A Personalized Approach to Parkinson’s Disease Patients Based on Founder Mutation Analysis (2016) (20)
- Head-Up Tilt Testing for Detecting Orthostatic Hypotension: How Long Do We Need to Wait? (2014) (20)
- Statin adherence and the risk of Parkinson's disease: A population-based cohort study (2017) (20)
- A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers (2016) (19)
- The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease (2015) (19)
- Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease (2017) (19)
- Pharmacokinetics of Etilevodopa Compared to Levodopa in Patient's With Parkinson's Disease: An Open-label, Randomized, Crossover Study (2003) (19)
- Intact working memory in non‐manifesting LRRK2 carriers – an fMRI study (2016) (19)
- Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk? (2019) (19)
- Estimation of Parkinson’s disease survival in Israeli men and women, using health maintenance organization pharmacy data in a unique approach (2012) (19)
- What predicts falls in Parkinson disease?: Observations from the Parkinson's Foundation registry (2018) (19)
- Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls (2019) (18)
- Hemiparkinsonism–hemiatrophy syndrome may mimic early‐stage cortical–basal ganglionic degeneration (1992) (18)
- Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease. (2014) (18)
- Single center experience with medical cannabis in Gilles de la Tourette syndrome. (2019) (18)
- Long-Term Remission of Idiopathic Cervical Dystonia after Treatment with Botulinum Toxin (2000) (18)
- Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurology. (1994) (18)
- Sensitivity of Neuropsychological Tests to Identify Cognitive Decline in Highly Educated Elderly Individuals: 12 Months Follow up. (2015) (18)
- The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot study. (1997) (18)
- Botulinum toxin in the treatment of tardive dystonia. (1997) (18)
- Freezing Phenomenon, the Fifth Cardinal Sign of Parkinsonism (1998) (18)
- Brain glucose metabolism and dopamine D2 receptor analysis in a patient with hemiparkinsonism‐hemiatrophy syndrome (1993) (17)
- Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial (2021) (17)
- Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity (2021) (17)
- An open trial of amantadine and buspirone for cerebellar ataxia: a disappointment (2000) (17)
- Mobility, mood and site of care impact health related quality of life in Parkinson's disease. (2014) (16)
- Altered reward-related neural responses in non-manifesting carriers of the Parkinson disease related LRRK2 mutation (2018) (16)
- Appreciation of humor is decreased among patients with Parkinson's disease. (2012) (16)
- Fighting the risk of developing Parkinson's disease; clinical counseling for first degree relatives of patients with Parkinson's disease (2011) (16)
- How Attention Modulates Encoding of Dynamic Stimuli (2016) (15)
- Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson’s Disease and Their First-Degree Unaffected Relatives (2018) (15)
- Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease (2011) (15)
- Combining transcranial direct current stimulation with a motor-cognitive task: the impact on dual-task walking costs in older adults (2021) (15)
- Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study. (2018) (15)
- Pisa Syndrome in Parkinson's Disease: Electromyographic Aspects and Implications for Rehabilitation (2015) (15)
- Levodopa therapy can ameliorate tetrabenazine‐induced parkinsonism (1999) (15)
- Efficacy of Rotigotine at Different Stages of Parkinson’s Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage (2016) (15)
- Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease (2021) (15)
- Neural patterns underlying the effect of negative distractors on working memory in older adults (2017) (15)
- Network abnormalities among non‐manifesting Parkinson disease related LRRK2 mutation carriers (2019) (14)
- Interest in Genetic Testing in Ashkenazi Jewish Parkinson’s Disease Patients and Their Unaffected Relatives (2015) (14)
- Parkinsons disease patients perspective on context aware wearable technology for auditive assistance (2009) (14)
- Does Cognitive Impairment Affect Rehabilitation Outcome in Parkinson’s Disease? (2016) (14)
- Down-regulation of B cell-related genes in peripheral blood leukocytes of Parkinson's disease patients with and without GBA mutations. (2016) (14)
- Survival rates among Parkinson's disease patients who carry mutations in the LRRK2 and GBA genes (2018) (14)
- Absence of mutations in ATM, the gene responsible for ataxia telangiectasia in patients with cerebellar ataxia (1999) (14)
- ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study. (2021) (14)
- Gait and mental function: the interplay between walking, behavior and cognition (2007) (14)
- Focused and Sustained Attention Is Modified by a Goal-Based Rehabilitation in Parkinsonian Patients (2017) (14)
- O1-03-02 Computer based cognitive training with mindfit® improved cognitive performances above the effect of classic computer games: Prospective, randomized, double-blind intervention study in the elderly (2007) (13)
- Levodopa-carbidopa intestinal gel (LCIG) infusion during pregnancy and delivery: first documented case. (2014) (13)
- Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome. (1993) (13)
- Is heart rate variability related to gait impairment in patients with Parkinson's disease? A pilot study. (2009) (12)
- Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease (2019) (12)
- Increased Activation of the Frontal Lobe is associated with Freezing of Gait in Patients with Parkinson's disease: an fNIRS study (P6.074) (2015) (12)
- Dysphagia characteristics in Huntington’s disease patients: insights from the Fiberoptic Endoscopic Evaluation of Swallowing and the Swallowing Disturbances Questionnaire (2018) (12)
- Subcutaneous Levodopa Infusion for Parkinson's Disease: 1‐Year Data from the Open‐Label BeyoND Study (2021) (12)
- Changes in the EEG spectral power during dual-task walking with aging and Parkinson’s disease: initial findings using Event-Related Spectral Perturbation analysis (2020) (12)
- A Group Intervention Model for Speech and Communication Skills in Patients With Parkinson's Disease (2005) (12)
- Discussion of Research Priorities for Gait Disorders in Parkinson's Disease (2021) (12)
- Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI). (2019) (12)
- CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking (2014) (11)
- Can a single lower trunk body-fixed sensor differentiate between level-walking and stair descent and ascent in older adults? Preliminary findings. (2016) (11)
- SEPT14 Is Associated with a Reduced Risk for Parkinson’s Disease and Expressed in Human Brain (2016) (11)
- Paroxysmal locomotion gait disturbances in Parkinson's disease. (2001) (11)
- Schema benefit vs. proactive interference: Contradicting behavioral outcomes and coexisting neural patterns (2017) (11)
- Mobility and exercise in movement disorders. (2009) (11)
- Effectiveness of a Goal-Based Intensive Rehabilitation in Parkinsonian Patients in Advanced Stages of Disease. (2018) (10)
- Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers (2021) (10)
- Subthalamic Neurons Encode Both Single- and Multi-Limb Movements in Parkinson’s Disease Patients (2017) (10)
- The neural correlates of falls: Alterations in large-scale resting-state networks in elderly fallers. (2020) (10)
- What happens before the first step? A New Approach to Quantifying Gait Initiation Using a Wearable Sensor. (2019) (10)
- Pharmacokinetics and safety of ND0612L (levodopa/carbidopa for subcutaneous infusion): Results from a phase II study in moderate to severe Parkinson’s disease (P1.187) (2015) (10)
- [Botulinum toxin injection effective for post-peripheral facial nerve palsy synkinesis]. (1998) (10)
- Distinct Effects of Motor Training on Resting-State Functional Networks of the Brain in Parkinson’s Disease (2020) (10)
- Dopaminergic therapy and prefrontal activation during walking in individuals with Parkinson’s disease: does the levodopa overdose hypothesis extend to gait? (2020) (10)
- "Brain Screen": A self-referral, screening program for strokes, falls and dementia risk factors. (2006) (10)
- Melatonin‐induced withdrawal emergent dyskinesia and akathisia (1999) (9)
- Parkinson's disease patients first treated at age 75 years or older: a comparative study. (2014) (9)
- Subdivision of essential tremor patients according to physiologic characteristics (2004) (9)
- Successful Negotiation of Anticipated and Unanticipated Obstacles in Young and Older Adults: Not All Is as Expected (2019) (9)
- Neurocognitive Plasticity Is Associated with Cardiorespiratory Fitness Following Physical Exercise in Older Adults with Amnestic Mild Cognitive Impairment. (2021) (9)
- Reduced mind wandering in patients with Parkinson's disease. (2017) (8)
- Anemia in men and increased Parkinson's disease risk: A population-based large scale cohort study. (2019) (8)
- Vasomotor reactivity as a predictor for syncope in patients with orthostatism (2012) (8)
- Reversible freezing of gait caused by dural arteriovenous fistula and congestion of the globus pallidus (2012) (8)
- A new approach to quantifying the EEG during walking: Initial evidence of gait related potentials and their changes with aging and dual tasking (2019) (8)
- The effect of deprenyl treatment on directional and velocity control of arm movement in patients with early stages of Parkinson's disease. (1999) (8)
- Gait Disorders in Patients with Cognitive Impairment or Dementia (2014) (8)
- The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews (2021) (8)
- P2.097a The new revised freezing of gait questionnaire, a reliable and valid instrument to measure freezing in Parkinson's disease? (2008) (8)
- Multitarget Transcranial Electrical Stimulation for Freezing of Gait: A Randomized Controlled Trial (2021) (8)
- [Botulin toxin for spasticity in spinal cord damage by treating the motor endplate]. (2000) (8)
- Sensor-Based and Patient-Based Assessment of Daily-Living Physical Activity in People with Parkinson’s Disease: Do Motor Subtypes Play a Role? (2020) (8)
- Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants (2014) (8)
- The Modifying Effect of Age on Survival in Parkinson’s Disease: A Population-Based Cohort Study (2019) (7)
- Camptocormia: don’t forget muscle disease in the movement disorder clinic (2012) (7)
- Deprenyl monotherapy improves visuo-motor control in early parkinsonism. (1998) (7)
- Differential changes in visual and auditory event-related oscillations in dementia with Lewy bodies (2020) (7)
- Alterations in conflict monitoring are related to functional connectivity in Parkinson's disease (2016) (7)
- Neural Variability in the Prefrontal Cortex as a Reflection of Neural Flexibility and Stability in Patients With Parkinson Disease (2021) (7)
- Effect of Rivastigmine on Mobility of Patients with Higher-Level Gait Disorder: A Pilot Exploratory Study (2014) (7)
- Myelopathy as a complication of diabetes mellitus. (1991) (7)
- Event-related oscillations differentiate between cognitive, motor and visual impairments (2022) (7)
- Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromes (2016) (7)
- Who will remain tremor dominant? The possible role of cognitive reserve in the time course of two common Parkinson’s disease motor subtypes (2018) (6)
- Altered Topology in Information Processing of a Narrated Story in Older Adults with Mild Cognitive Impairment. (2016) (6)
- Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. (2017) (6)
- Quantitative digital clock drawing test as a sensitive tool to detect subtle cognitive impairments in early stage Parkinson's disease. (2021) (6)
- Addressing the Challenges of Clinical Research for Freezing of Gait in Parkinson's Disease (2021) (6)
- [18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study. (2020) (6)
- Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson’s Disease: A Post Hoc Analysis (2015) (6)
- ND0612, a novel liquid formulation of levodopa/carbidopa for subcutaneous infusion in patients with Parkinson’s disease achieves stable levodopa plasma levels when administered in low and high doses (S4.002) (2017) (6)
- Treatment of Gait and Balance Disorders (2008) (6)
- 294 VIRTUAL REALITY FOR GAIT TRAINING IN PARKINSON'S DISEASE: A FEASIBILITY STUDY (2010) (6)
- Efficient Estimation of Nonparametric Genetic Risk Function with Censored Data. (2015) (5)
- Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients☆☆☆ (2020) (5)
- Evaluation of freezing of gait severity in patients with Parkinson's disease: the perception of caregivers (2006) (5)
- Multidisciplinary intensive outpatient rehabilitation program for patients with moderate-to-advanced Parkinson's disease. (2021) (5)
- P2-406: Improving cognitive performance in elderly subjects using computerized cognitive training (2008) (5)
- Interaction between cognition and gait in patients with Parkinson’s disease (2010) (5)
- Does Time-of-Day Influence Postural Control and Gait? A Review of the Literature (2021) (5)
- Which obstacle attributes place additional demands on higher-level cognitive function in patients with Parkinson's disease? (2020) (5)
- Freezing of gait: Risk factors and clinical characteristics (2006) (5)
- 15.15 Does turning differ from walking? Turning duration,gait indices and fall risk in Parkinson's disease and idiopathic fallers (2005) (5)
- Clinical Evaluation and Treatment of Gait Disorders in Parkinson’s Disease (2004) (5)
- The role of functional neurosurgery in Parkinson's disease. (2000) (5)
- Gait and cognitive abnormalities are associated with regional cerebellar atrophy in elderly fallers - A pilot study. (2021) (5)
- Biochemical markers for severity and risk in GBA and LRRK2 Parkinson’s disease (2021) (4)
- Two Ethnic Clusters with Huntington Disease in Israel: The Case of Mountain Jews and Karaites (2017) (4)
- Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers (2022) (4)
- Color Discrimination in Patients with Gaucher Disease and Parkinson Disease. (2015) (4)
- Pace of movement: the role of single neurons in the subthalamic nucleus. (2019) (4)
- A multimodal approach using TMS and EEG reveals neurophysiological changes in Parkinson's disease. (2021) (4)
- Whole brain and deep gray matter structure segmentation: Quantitative comparison between MPRAGE and MP2RAGE sequences (2021) (4)
- Advantages of timing the duration of a freezing of gait-provoking test in individuals with Parkinson’s disease (2020) (4)
- Age Specific Penetrance of the LRRK2 G2019S Mutation in the Michael J Fox Ashkenazi Jewish (AJ) LRRK2 Consortium (S17.002) (2014) (4)
- Erdheim-Chester disease presenting with chorea and mimicking IgG4-related disorder. (2019) (4)
- CHAPTER 36 – GAIT DISTURBANCES AND FALLS (2004) (4)
- Suicidal thoughts in patients with Parkinson’s disease treated by deep brain stimulation of the subthalamic nuclei: two case reports and review of the literature (2007) (4)
- Treatment of Parkinsonian Gait Disturbances (2005) (3)
- How attention modulates encoding of dynamic stimuli in older adults (2018) (3)
- Myotonic dystrophy with unilateral bulbar involvement. (1988) (3)
- The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program (2022) (3)
- Maximal aerobic capacity is associated with hippocampal cognitive reserve in older adults with amnestic mild cognitive impairment (2020) (3)
- Associations between visual hallucinations and impaired visuo-spatial abilities in dementia with Lewy bodies. (2021) (3)
- [Botulinum toxin for palatal myoclonus and spastic dysphonia]. (1993) (3)
- Sexuality in Parkinson’s disease (2009) (3)
- "Brain Screen" (2006) (3)
- Gait Disorders in Parkinson’s Disease (2012) (3)
- Gastric Dysfunction in Parkinson’s Disease (2013) (3)
- Estimation of genetic risk function with covariates in the presence of missing genotypes (2017) (3)
- PARK16 locus: Differential effects of the non-coding rs823114 on Parkinson's disease risk, RNA expression, and DNA methylation. (2021) (3)
- Is homocysteine a causal and treatable risk factor for stroke (2007) (3)
- Low cerebrospinal fluid volume and the risk for post-lumbar puncture headaches (2020) (3)
- Repeated Intravenous Amantadine Infusions in Advanced Parkinsonism: Experience of a Large Movement Disorder Center. (2019) (3)
- C9orf72-G4C2 Intermediate Repeats and Parkinson’s Disease; A Data-Driven Hypothesis (2021) (2)
- Advanced‐Stage Parkinson's Disease: From Identification to Characterization Using a Nationwide Database (2022) (2)
- Sexuality and Parkinson’s Disease (2003) (2)
- Impaired Inhibitory Control During Walking in Parkinson's Disease Patients: An EEG Study. (2021) (2)
- Amelioration of severe torsion dystonia with perphenazine. (1990) (2)
- BRAIN PLASTICITY FOLLOWING PHYSICAL TRAINING IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT: NEUROIMAGING STUDY (2017) (2)
- Physically active lifestyle is associated with attenuation of hippocampal dysfunction in healthy older adults (2021) (2)
- Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes (2014) (2)
- 15.14 Validation of the freezing of gait questionnaire (FOG-Q) in Parkinson's disease (2005) (2)
- Elevated titers of anti-thyroperoxidase antibodies in patients with multiple system atrophy: A pilot study (2013) (2)
- Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity (2022) (2)
- 15.16 Six weeks intensive treadmill training improvesgait and quality of life in patients with Parkinson's disease (2005) (2)
- Clinical experience using a 5 week treadmill training program with virtual reality to enhance gait (2013) (2)
- Interrelationships between Survival, Sex, and Blood Pressure in Patients with Multiple System Atrophy (2021) (2)
- [Botulinum toxin as a powerful new tool in the treatment of focal dystonia]. (1991) (2)
- The Added Value of 18F-FDOPA PET/CT in the Work-Up of Patients with Movement Disorders (2019) (2)
- Stepping up to meet the challenge of freezing of gait in Parkinson’s disease (2022) (2)
- Functional MRI in multiple sclerosis: a simple motor task gives insights into a complex disease (2005) (2)
- Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort (2022) (2)
- 2.11 A prospective study of older adults with a high level gait disorder: Evidence for a neurodegenerative process (2005) (2)
- Physically Active Lifestyle Is Associated With Attenuation of Hippocampal Dysfunction in Cognitively Intact Older Adults (2021) (2)
- Standardized quantitative measurements in Parkinson's disease. (1999) (2)
- Distinguishing Dementia With Lewy Bodies From Alzheimer's Disease: What is the Influence of the GBA Genotype in Ashkenazi Jews? (2019) (2)
- Dr. Sirota and Colleagues Reply (2001) (2)
- The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A44. (2021) (1)
- Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort (2023) (1)
- AGE-ASSOCIATED FACTORS CONTRIBUTING TO OBSTACLE NEGOTIATION ABILITIES: NOT ALL IS AS EXPECTED (2017) (1)
- Real World Pharmacological First Treatment Patterns of Patients With Parkinson Disease and Disease Duration: A Large-Scale Cohort Study Using an Health Maintenance Organization Database (2021) (1)
- Increased substantia nigra echogenicity in LRRK2 family members without mutations (2018) (1)
- 9.14 Gait disturbances in depressed patients: Effects of pharmacologic therapy (2005) (1)
- P1.010 The Dynamic Gait Index provides insight into stair climbing and fear of falling in healthy elderly men and women (2008) (1)
- Limited Ability to Adjust N2 Amplitude During Dual Task Walking in People With Drug-Resistant Juvenile Myoclonic Epilepsy (2022) (1)
- A Case with Beta‐Propeller Protein Associated Neurodegeneration with Smooth Response to Levodopa Treatment (2018) (1)
- P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease (2022) (1)
- Distinguishing Dementia With Lewy Bodies From Alzheimer Disease (2019) (1)
- Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant (2022) (1)
- disease: the effects of dual tasking Bilateral coordination of gait and Parkinson's (2009) (1)
- Acetylcholinesterase Inhibitors in the Treatment of Dementia in Parkinson’s Disease (2003) (1)
- Event-Related Oscillations in Dementia with Lewy Bodies with a Mutation in the GBA Gene (2021) (1)
- The instrumented Timed Up and Go test : Potential for assessing alterations in Parkinson ' s disease clinical subtypes (2013) (1)
- Daily-Living Freezing of Gait as Quantified Using Wearables in People With Parkinson Disease: Comparison With Self-Report and Provocation Tests (2022) (1)
- BRAIN PLASTICITY FOLLOWING PHYSICAL TRAINING IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT: NEUROIMAGING STUDY (2017) (1)
- 15.33 Methylphenidate treatment improves cognitive function and gait performance in patients with Parkinson's disease (2005) (1)
- 186 AGE-ASSOCIATED CHANGES IN THE EFFECTS OF MENTAL LOADING ON THE BILATERAL COORDINATION OF GAIT (2010) (1)
- Hereditary juvenile-onset craniocervical predominant generalized dystonia with parkinsonism. (2000) (1)
- IS COGNITIVE DECLINE SIMILAR AMONG PARKINSON’S DISEASE MOTOR SUB-TYPES? A PROSPECTIVE STUDY (2017) (1)
- Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale (2020) (1)
- Gait Disturbances in Aging (2010) (1)
- GBA Mutations in REM Sleep Behavior Disorder and Parkinson’s Disease (S19.007) (2016) (1)
- Automated detection of missteps during community ambulation in patients with Parkinson’s disease: a new approach for quantifying fall risk in the community setting (2014) (1)
- Automatic quantification of tandem walking using a wearable device: new insights into dynamic balance and mobility in older adults. (2020) (1)
- Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease (2022) (1)
- LONG-TERM EFFECT OF REPEATED INJECTIONS OF BOTULINUM TOXIN IN CHILDREN WITH CEREBRAL PALSY – A PROSPECTIVE STUDY (2006) (1)
- 15.27 Characteristics of bilateral coordination of gait in patients with Parkinson's disease prone to freezing (2005) (1)
- A Simple Tool to Reach Populations at Risk for Developing Dementia and Alzheimer's Disease. (2015) (1)
- P1.113 Obstacle avoidance while walking on a motorized treadmill provokes freezing of gait (2007) (1)
- Decreased delta-band event-related power in dementia with Lewy bodies with a mutation in the glucocerebrosidase gene (2022) (1)
- Unique Ataxia-Oculomotor Apraxia 2 (AOA2) in Israel with Novel Variants, Atypical Late Presentation, and Possible Identification of a Poison Exon (2022) (1)
- How Do I Examine Parkinsonian Gait? (2016) (1)
- The contribution of postural control and bilateral coordination to the impact of dual tasking on gait (2013) (0)
- P1.123 Is turning during walking an automated motor task, or is it a complex cognitive action? (2008) (0)
- Variants in PSMB9 and FGR differentially affect Parkinson's disease risk in GBA and LRRK2 mutation carriers. (2023) (0)
- SEPT14 Is Associated with a Reduced Risk for Parkinson’s Disease and Expressed in Human Brain (2016) (0)
- 2.114 PERIPAPILLARY RETINAL NERVE FIBER LAYER THICKNESS IN PATIENTS WITH PARKINSON'S DISEASE, PATIENTS WITH DIFFERENT GENETICS STATUS (2012) (0)
- elf-Report of Missteps in Older Adults: A Valid Proxy f Fall Risk? (0)
- Reply to: “Letter on Discussion of Gait Research” (2022) (0)
- A.3 Rotigotine (Neupro®), a new non-ergolinic dopamine agonist in a transdermal patch, for early and late stages of Parkinson'ss Disease (2006) (0)
- Altered reward-related neural responses in non-manifesting carriers of the Parkinson disease related LRRK2 mutation (2018) (0)
- 1.303 MEASURING ARM SWING DURING GAIT IN PATIENTS WITH PARKINSON'S DISEASE USING WEARABLE SENSORS – A FEASIBILITY STUDY (2012) (0)
- Functional Brain Plasticity Following Physical Training in Amnestic Mild Cognitive Impairment: A Neuroimaging Study 2531 June 1 1 15 PM - 1 30 PM (2018) (0)
- 18.10 Idiopathic “cautious” gait disorder of the elderly:More than fear of falling (2005) (0)
- Model-based and Model-free Machine Learning Techniques for Diagnostic Prediction and Classification of Clinical Outcomes in Parkinson’s Disease (2018) (0)
- Klinische Wirksamkeit von Pramipexol und transdermalem Rotigotin bei Patienten mit fortgeschrittener Parkinson-Erkrankung: CLEOPATRA-PD (2007) (0)
- Combining tDCS With a Motor-Cognitive Task to Reduce the Negative Impact of Dual-Tasking on the Gait of Older Adults (2020) (0)
- P2.069 Non-rhythmic auditory stimulation prior to walking may improve gait dynamics in patients with moderate Parkinson's disease (2008) (0)
- 14th Italian Congress of Neuroepidemiology. Milan, Italy, November 21-22, 2014: Abstracts (2014) (0)
- The modifying effect of age on survival in Parkinson’s disease: Big data analysis (2018) (0)
- R869C mutation in molecular motor KIF17 gene is involved in dementia with Lewy bodies (2021) (0)
- The Age at Motor Symptoms Onset in LRRK2-Associated Parkinson's Disease is Affected by a Variation in the MAPT Locus: A Possible Interaction (2011) (0)
- Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers (2022) (0)
- PL4.3 Selected oral abstract: Emotion, cognition, freezing of gait and dual tasking in patients with advanced Parkinson's disease: a volatile mixture (2008) (0)
- III.2 Causes for psychosis in Parkinson's Disease (2006) (0)
- P2.018 The Timed Up and Go test: more than meets the eye (2008) (0)
- TREADMILL TRAINING WITH VIRTUAL REALITY TO REDUCE FALLS AMONG OLDER ADULTS: RCT RESULTS. (2017) (0)
- Increased frontal brain activation during walking while dual tasking: an fNIRS study in healthy young adults (2014) (0)
- Objective detection of freezing of gait elicited by obstacle avoidance during treadmill walking in Parkinson's disease (2009) (0)
- Effekt des Rotigotin-Pflasters auf frühmorgendliche Beweglichkeit, Schlafqualität und Tagesschläfrigkeit bei Patienten mit idiopathischer Parkinson-Erkrankung. Ergebnisse einer multizentrischen, multinationalen Studie (2007) (0)
- Gait dynamics in older adults with a high level gait disorder: a prospective study (2006) (0)
- Paroxysmal Slow-Wave Events Are Uncommon in Parkinson’s Disease (2023) (0)
- P1.060 Freezing of gait in older adults with higher-level gait disorders: association with impaired executive function (2008) (0)
- P2.016 Cognitive and motor mediators of the changes in gait stability during dual tasking in healthy older adults (2008) (0)
- Pergolide como terapia coadyuvante en enfermedad de Parkinson evaluado mediante la escala de evaluación corta (SPES) (2000) (0)
- DO UNIQUE SIGNATURES OF MOBILITY PREDICT DISTINCT ADVERSE HEALTH OUTCOMES IN OLDER ADULTS? PROSPECTIVE FINDINGS (2018) (0)
- 058 DISORDERS OF GAIT WITH FEAR OF FALL IN COMMUNITY DWELLING ELDERS (2010) (0)
- A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers (2016) (0)
- P2.015 Effects of motor and cognitive tasks on hemodynamic parameters in orthostatic hypotension (2008) (0)
- When is Higher Level Cognitive Control Needed for Locomotor Tasks Among Patients with Parkinson’s Disease? (2017) (0)
- Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson’s Disease and Their First-Degree Unaffected Relatives (2018) (0)
- Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study (2022) (0)
- 136 DOES HEART RATE CHANGE WITH FREEZING OF GAIT IN PATIENTS WITH PARKINSON'S DISEASE? (2010) (0)
- P1.032 Walking direction and dual tasking interactions: disparate effects in patients with DYT1 dystonia and healthy controls (2008) (0)
- 166 THE EFFECT OF EXPLICIT PRIORITIZATION ON DUAL TASK PERFORMANCE IN ELDERLY SUBJECTS AND PATIENTS WITH PARKINSON'S DISEASE (2010) (0)
- Baseline Characteristics of Participants of the SPARK Trial, a Phase 2 Study of the anti-alpha-synuclein antibody Cinpanemab (BIIB054) in Parkinson’s Disease (1579) (2020) (0)
- Decreased aperiodic neural activity in Parkinson's disease and dementia with Lewy bodies. (2023) (0)
- 9.23 Mental loading increases gait asymmetry and stride-to-stride variability in patients with Parkinson's disease (2005) (0)
- An analysis of cognitive and behavioral features of MSA-P and MSA-C patients. (2010) (0)
- REM sleep behavior disorder (RBD) may not be a promising marker for development of LRRK2 PD as measured by RBD Sleep Questionnaire (P2.150) (2015) (0)
- Neural Plasticity INTERFERENCE TO CONSOLIDATION PHASE GAINS IN LEARNING A NOVEL MOVEMENT SEQUENCE BY HANDWRITING IS DEPENDENT ON LATERALITY AND THE LEVEL OF EXPERIENCE WITH THE WRITTEN SEQUENCE (2007) (0)
- [Clinical aspects and treatment of 95 patients with hemifacial spasm]. (2002) (0)
- 013 DOES A SYNERGISM BETWEEN COGNITIVE LOADING AND CURVED PATHS PREDISPOSE FREEZING OF GAIT IN PARKINSON'S DISEASE? (2010) (0)
- Interrelationships between survival, sex and blood pressure in patients with multiple system atrophy (2018) (0)
- Gait Speed and Variability Dual-Task Performance? Effects of Age and Sex on How Does Explicit Prioritization Alter Walking During (2013) (0)
- Abnormal gait and motor cortical processing in drug‐resistant juvenile myoclonic epilepsy (2023) (0)
- Differential neural activation in healthy older adults compared to subjects with Parkinson's disease during motor imagery of walking in virtual environments (2015) (0)
- Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s Disease (2022) (0)
- Peripapillary retinal nerve fiber layer thickness in patients with Parkinson’s disease and multiple system atrophy (2011) (0)
- 2.246 Treatment of early morning and night time motor symptoms with rotigotine transdermal system in Parkinson's disease patients (2007) (0)
- [Plasmapheresis in neurological diseases]. (1987) (0)
- Contens Vol. 43, 2014 (2015) (0)
- Gait in an Ambulatory Physical Therapy Service Training Program With Virtual Reality to Enhance Clinical Experience Using a 5-Week Treadmill (2014) (0)
- Disease severity and prefrontal cortex activation during obstacle negotiation among patients with Parkinson's disease: Is it all as expected? (2022) (0)
- The interplay between structural and functional connectivity in early stage Parkinson's disease patients (2022) (0)
- 3.427 Compliance to treatment for dysphagia in patients with Parkinson's disease (2007) (0)
- Gait disturbances in Parkinsonism (2010) (0)
- Identifying axial and cognitive correlates in patients with Parkinson’s disease motor subtype using the instrumented Timed Up and Go (2013) (0)
- Ventral Striatum Involvement In Non Manifesting Carriers Of The G2019S Mutation In The LRRK2 Gene (P6.077) (2015) (0)
- Rotigotin transdermales System (Neupro®) bei Patienten mit idiopathischem Parkinson-Syndrom im fortgeschrittenen Krankheitsstadium in Kombination mit Levodopa: Ergebnisse einer Plazebo- und Pramipexol-kontrollierten Studie (2006) (0)
- P1.017 The use of 18FDG-PET for differentiation of Parkinson's disease from Lewy body disease early in the course of the disease (2008) (0)
- CCR5‐Δ32 polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients (2022) (0)
- treatment of higher level gait disturbances with rivastigmine: A pilot study : p220 (2005) (0)
- Cancer comorbidity among Parkinson's Disease patients; a population based large-scale cohort study (2016) (0)
- Dual tasking affects gait performance but not automaticity in functional gait disorders: A new diagnostic biomarker. (2023) (0)
- 3.029 SUBTLE DIFFERENCES IN COGNITIVE FUNCTION OF HEALTHY G2019S LRRK2 MUTATION CARRIERS (2012) (0)
- P2.004 Can methylphenidate reduce fall risk in community living older adults? RCT for gait & fall risk relations on executive function (2008) (0)
- Combining transcranial direct current stimulation with a motor-cognitive task: the impact on dual-task walking costs in older adults (2021) (0)
- Oral session 37 — Mouvement disorders (2) (2005) (0)
- P1.042 Task-dependent in.uence of walking on “dual tasks” in young and older adults: implications regarding “posture first” (2008) (0)
- SPARC: a new approach to quantifying gait smoothness in patients with Parkinson’s disease (2018) (0)
- P2.055 Which aspects of executive function explain the dual tasks effects on gait speed (2008) (0)
- Parkinson's Progression Markers Initiative brain autopsy program. (2022) (0)
- Parkinson Disease Phenotype in Ashkenazi Jews with and without LRRK2 Mutations (IN2-2.001) (2013) (0)
- Grey and White Matter Pathways Underlying the Relationship Between Aerobically Active Lifestyle, Cardiorespiratory Function, and Episodic Memory in the Aging Human Brain (2020) (0)
- Enhancing hope, control and meaningfulness through group-work in the treatment of Parkinson (1994) (0)
- 2.115 PERIPAPILLARY RETINAL NERVE FIBER LAYER THICKNESS IN PATIENTS WITH PARKINSON'S DISEASE AND MULTIPLE SYSTEM ATROPHY (2012) (0)
- Genetic Creutzfeldt Jakob disease: Can MRI serve as an early diagnostic biomarker? (2021) (0)
- Neural Synchrony During Naturalistic Information Processing Is Associated With Aerobically Active Lifestyle and Cardiorespiratory Fitness in Cognitively Intact Older Adults (2022) (0)
- Higher-Level Cognitive Function and Obstacle Attributes: An fNIRS Study in Older Adults With Parkinson’s Disease (2020) (0)
- The interrelationships between gait and cognitive function (2005) (0)
- Long-term safety and efficacy of transdermal rotigotine in advanced Parkinson's disease (2008) (0)
- Time related patterns of blood pressure response in patients with orthostatic hypotension during prolonged tilt testing (2013) (0)
- O.002 Piloting the NPF data-driven quality initiative to improve Parkinson's disease management (2009) (0)
- Blood pressure variations are not predictive for survival length in multiple systems atrophy (2015) (0)
- Freezing of Gait Questionnaire--Self Administered Version (2014) (0)
- Evidence for increased completed suicide in first-degree relatives of LRRK2 G2019S mutation Parkinson’s disease (2018) (0)
- A novel performance scoring quantification framework for stress test set-ups (2022) (0)
- Toxicity of the specific antimuscarinic agent methoctramine and other non-specific anticholinergic drugs in human neuroblastoma cell lines in vitro. (1993) (0)
- The Influence of GBA and LRRK2 on Mood Disorders in Parkinson's Disease (2023) (0)
- Ondansetron, a 5-HT3 antagonist, improves tardive dyskinesia (1999) (0)
- 3.054 THE PREVALENCE OF CANCER IN PATIENTS WITH PARKINSON'S DISEASE WHO ARE CARRIERS OF THE G2019S MUTATION IN THE LRRK2 GENE (2012) (0)
- Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients With Parkinson's Disease and a GBA Mutation: Results From Part 1 of the Randomised, Double-Blinded, Placebo-Controlled MOVES-PD Trial (2021) (0)
- The role of the prefrontal cortex in freezing of gait in Parkinson’s disease: insights from a deep repetitive transcranial magnetic stimulation exploratory study (2017) (0)
- P1.034 The effects of reducing fear of falling on locomotion in older adults with a higher-level gait disorder (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nir Giladi?
Nir Giladi is affiliated with the following schools:
